Journal of ISAKOS : joint disorders & orthopaedic sports medicine · 2026
Anterior cruciate ligament reconstruction with modified Lemaire lateral extra-articular tenodesis is associated with favorable subjective knee function at short-term follow-up in adolescents.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Espinosa Maximiliano, Pastrián Daniel, González Javier, Echeverría Francisca, Donoso Rodrigo, De La Fuente Gonzalo
Аннотация
INTRODUCTION/OBJECTIVE: Anterior cruciate ligament (ACL) reconstruction in adolescents is associated with higher graft failure rates than in adults. Lateral extra-articular tenodesis (LET) may improve rotational stability and potentially reduce graft failure in this high-risk population. This study aimed to evaluate functional outcomes, return to sport (RTS), graft failure, and reintervention rates in adolescents undergoing ACL reconstruction combined with modified Lemaire LET.
METHODS: This prospective single-center cohort included patients younger than 18 years who underwent primary ACL reconstruction using a hamstring autograft combined with modified Lemaire LET and had a minimum follow-up of 12 months. Outcomes included the Lysholm score, International Knee Documentation Committee (IKDC) Subjective Knee Form, RTS rate and timing, graft failure, and reinterventions.
RESULTS: Fifty-five patients were included, with a median age of 16.8 years (interquartile range [IQR], 16.1-17.6); 36 patients were male (65.5%). The mean follow-up was 28.7 months (range, 12-36 months). At final follow-up, the median Lysholm score was 94.0 (IQR, 89.5-96.0), and the median subjective IKDC score was 85.0 (IQR, 80.0-89.0). RTS was achieved in 53 patients (96.4%) at a median of 12.0 months after surgery (IQR, 11.8-13.0). Graft failure occurred in five patients (9.1%) at a median of 17.0 months postoperatively (IQR, 15.0-17.0), and nine patients (16.4%) underwent ipsilateral knee reintervention during follow-up, including revision ACL reconstruction and additional meniscal or lateral extra-articular procedures.
CONCLUSION: In this prospective cohort of adolescents undergoing ACL reconstruction combined with modified Lemaire lateral extra-articular tenodesis, short-term subjective knee function was favorable, return to organized sport occurred in 96.4% of patients, and graft failure occurred in 9.1%.
LEVEL OF EVIDENCE: Level IV, therapeutic case series.
METHODS: This prospective single-center cohort included patients younger than 18 years who underwent primary ACL reconstruction using a hamstring autograft combined with modified Lemaire LET and had a minimum follow-up of 12 months. Outcomes included the Lysholm score, International Knee Documentation Committee (IKDC) Subjective Knee Form, RTS rate and timing, graft failure, and reinterventions.
RESULTS: Fifty-five patients were included, with a median age of 16.8 years (interquartile range [IQR], 16.1-17.6); 36 patients were male (65.5%). The mean follow-up was 28.7 months (range, 12-36 months). At final follow-up, the median Lysholm score was 94.0 (IQR, 89.5-96.0), and the median subjective IKDC score was 85.0 (IQR, 80.0-89.0). RTS was achieved in 53 patients (96.4%) at a median of 12.0 months after surgery (IQR, 11.8-13.0). Graft failure occurred in five patients (9.1%) at a median of 17.0 months postoperatively (IQR, 15.0-17.0), and nine patients (16.4%) underwent ipsilateral knee reintervention during follow-up, including revision ACL reconstruction and additional meniscal or lateral extra-articular procedures.
CONCLUSION: In this prospective cohort of adolescents undergoing ACL reconstruction combined with modified Lemaire lateral extra-articular tenodesis, short-term subjective knee function was favorable, return to organized sport occurred in 96.4% of patients, and graft failure occurred in 9.1%.
LEVEL OF EVIDENCE: Level IV, therapeutic case series.